- The shares of Agilon Health (AGL) recently received a $38 price target from Goldman Sachs. These are the details.
The shares of Agilon Health (AGL) recently received a $38 price target from Goldman Sachs.
Price target: $38
Rating: Buy
Analyst: Goldman Sachs analyst Jamie Perse
Perse initiated coverage of the company while pointing out that the company is well-positioned in the large and growing Medicare value-based care market. And the company’s capital-efficient go-to-market strategy is a key differentiator in this attractive market.
Source: pulse2.com
